483 Cardinal Health 414 Dec 2012

483 Cardinal Health 414 Dec 2012

Barbara Breithaupt FDA, Eric Dong FDA, Dandan Wang FDA$119.00 - Available Now

FDA investigators audited the Cardinal Health 414 - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 14 Dec 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Dec 2012
  • Location: Seattle, United States
  • FEI: 3003706047
Add To Cart